<DOC>
	<DOCNO>NCT00243217</DOCNO>
	<brief_summary>The objective trial demonstrate clinical efficacy four different dosage SPM 962 1.125 mg , 2.25 mg , 4.5 mg 6.75 mg ( correspond 2.5 cm2 , 5 cm2 , 10 cm2 15 cm2 patch size respectively ) RLS subject . It anticipate rotigotine ( SPM 936 ) effective placebo . The tolerability safety rotigotine assess .</brief_summary>
	<brief_title>Rotigotine Restless Legs Syndrome Dose Finding Trial</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Idiopathic Restless Leg Syndrome Subject respond previously , accord medical history information , LDopa therapy and/or treatment dopamine agonist , pretreated Secondary restless legs syndrome due , e.g. , renal insufficiency ( uremia ) , iron deficiency anemia , rheumatoid arthritis . Secondary restless legs syndrome associate previous concomitant therapy dopamine D2 receptor antagonist , butyrophenones , metoclopramid , atypical antipsychotic ( e.g. , olanzapine ) , tri tetracyclic antidepressant , mianserine , lithium H2blockers ( e.g. , cimetidine ) , due withdrawal drug anticonvulsant , benzodiazepine , barbiturate , hypnotic . History sleep disturbance like sleep apnea syndrome , narcolepsy , myoclonus epilepsy observe polysomnography ( PSG ) explore subject history . Clinically relevant cardiac dysfunction and/or arrhythmia ( e.g. , suspect conduction system dysregulations , second third degree AV block , complete leave right bundle branch block , sicksinussyndrome , congestive heart failure Class III IV NYHA , myocardial infarction within twelve month prior enrollment ) . Clinically relevant renal dysfunction ( serum creatinine &gt; 2.0 mg/dl ) Clinically relevant hepatic dysfunction ( total bilirubin &gt; 2.0 mg/dl ALT and/or AST great two time upper limit reference range ) . QTcinterval rest ECG &gt; 450 msec male &gt; 470 msec female . History symptomatic orthostatic hypotension within 28 day prior screen visit ( Visit 1 ) , systolic blood pressure ( SBP ) less 105mmHg trial entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>